Sherif H. Al- Hawarey, M.D.

Mailing Address : *939 SW Bond Ave.

#214. Portland 97239

Email: acwbz7@r.postjobfree.com

Cell: 312-***-****

EDUCATION:

**** – June 2016 Intervention pain management Fellowship

Oregon Health & Science University, Anesthesiology Department, learning comprehensive pain management with focus on the Pain procedure.

Sept. 2012 American Board of Psychiatry and Neurology

American Board of Medical Specialities

July 2010 - June 2011 Clinical Neurophysiology Fellowship

University of Saint Louis, MO, main focus on EMG/ NCS, EEG, Evoked potential, variety of clinical encounters with neuromuscular and epilepsy disorders, in addition to medical Botox injection.

July 2007 – Sept. 2008 Chief Resident, Neurology Residency Program

University of Illinois College of Medicine at Peoria, IL.

Spend two months at UMDNJ/ NJ exposed to plenty of

Cerebral ischemic pathology and interventional management

July 2005 - June 2007 Neurology Residency Program

University of Illinois College of Medicine at Peoria, Peoria, IL

July 2004 - June 2005 Resident, Internal Medicine (Preliminary)

University of Illinois College of Medicine at Peoria, Peoria, IL

April 1997 – Nov. 1998 House Officer (Intern, Neurology);

Al Sharq Hospital & Cairo University Hositals,

Cairo, Egypt

Sept 1989 - March 1997 M.D. degree (Bachelor of Medicine and Surgery)

Cairo University, Cairo, Egypt

PROFESSIONAL PROFILE & HOSPITAL APPOINTMENTS:

July 2013- June 2015 Salem Regional Hospital, Oregon.

Medical Director of Neurology Department.

Feb. 2013- July 2013 St. Anthony Hospital, Alton Illinois.

Neurologist.

August 2011- Jan. 2013 St. Mary’s Hospital, St Louis, MO.

Stroke Medical Director/Neurologist.

March 2011- June 2012 Lake regional Hospital, Osage beach, MO.

Neurologist, locum while working perm.

Dec. 2008 - June 2010 Rockford Memorial Hospital, Rockford, IL

Stroke Medical Director/Neurologist.

Sept. 2008 - Nov. 2008 Comp Health, Chicago.

Neurologist

Jan. 1999 - June 2004 United Neurology Center, Houston, TX

Physician Assistant

PRESENTATIONS:

1.AL-Hawarey SH. “Approach to Chorea.” Neurology Grand Rounds, University of Illinois College of Medicine at Peoria, June 20, 2006, Peoria, IL.

2.AL-Hawarey SH. “Therapeutic Potential of Medicinal Cannabis.” Neurology Grand Rounds, University of Illinois College of Medicine at Peoria, July 6, 2007, Peoria, IL.

3.AL-Hawarey SH. “Stroke in Children.” Neurology Grand Rounds, University of Illinois College of Medicine at Peoria, June 6, 2008, Peoria, IL.

4."Epilepsy classification and semiology" guided by video recording of seizure patients from SLU practice. 9/27/2010 at St. Louis University.

5.“Combined central and peripheral demyelinating disorders, reality or coincidence” Washington University, 2011.

RESEARCH:

1.AL-Hawarey S, Vijayappa MB, Alsorogi M, Clemson B, Joseph D, Mathews M, Talkad A, Jan Jahnel, Wiese K, Wang D. “Patients with Ventricular Assist Device Are Likely to Develop Strokes despite Anticoagulation” (Presented at the 32nd International Stroke Conference, February 2007, San Francisco, CA).

2.AL-Hawarey S, Vijayappa MB, Clemson B, Alsorogi M, Joseph D, Mathews M, Talkad A, Wiese K, Wang D. “The Rate of Stroke Associated with the use of Throated Ventricular Assist Device in Older Patients” (Presented at the 16th European Stroke Conference, May 2007, Glasgow, UK).

3.AL-Hawarey S, Vijayappa MB, Wang D, Alsorogi M, Joseph D, Mathews M, Talkad A, Clemson B. “Stroke and device related infection are common in patients with Throated® or Heartmate® Ventricular Assist Devices” (submitted for presentation at European Society of Cardiology, Heart Failure meeting, June 2007, Hamburg, Germany).

4.Retrospective study comparing Multiple Sclerosis and CIDP patients including the Neuroimaging, electrodiagnostic studies, blood work, spinal fluid analysis, history and demography. Conducted by AL-Hawarey, M.D

5. Retrospective study focused on predicting the response to the Neurostimulation treatment, VNS, of refractory Epilepsy with comparison between adult and Pediatric population. Conducted by AL-Hawarey, M.D.

6.On site primary investigator, clinical trial, Gilenya long term side effects.

CERTIFICATION:

1.Neurology Board certified.

2.Neurophysiology Board eligible.

3.Epilepsy Board eligible.

4.Pain Board eligible.

PROFESSIONAL MEMBERSHIP:

1.American Academy of Neurology.

2.American Heart Association/American Stroke Association.

3.American Medical Association.

4.American Academy of the Neurophysiology.

AWARDS:

1.Best research project in the 3rd year medical school.

2.Highest in-training exam score

LICENSURE:

1.Illinois Permanent Physician Licensure, Active.

2.Missouri Permanent Physician Licensure, Active.

3.Oregon Physician Licensure, Active.

LANGUAGES:

English.

Spanish: moderate conversational.

Arabic: fluent

EXTRACURRICULAR ACTIVITIES:

Concerts, hiking, fishing reading especially national geography and similar articles, playing soccer and practicing water and mechanical sports.

Contact this candidate